Sunmax Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,026	1,818	1,689	1,400	1,036
Revenue Growth (YoY)	11.45%	7.64%	20.64%	35.19%	21.01%
Cost of Revenue	437.54	339.35	284.1	207.27	141.21
Gross Profit	1,589	1,479	1,405	1,193	894.45
Selling, General & Admin	548.09	512.52	481.35	407.22	502.21
Research & Development	42.23	39.18	28.74	17.97	24.63
Operating Expenses	590.32	551.7	510.1	424.8	527.08
Operating Income	998.31	926.96	894.8	768	367.37
Interest Expense	-4.88	-5.95	-2.94	-1.35	-2.81
Interest & Investment Income	12.17	11.24	13.2	7.18	3.79
Currency Exchange Gain (Loss)	-	17.12	1.95	2.43	-3.03
Other Non Operating Income (Expenses)	8.98	4.84	2.51	0.46	-6.23
EBT Excluding Unusual Items	1,015	954.22	909.52	776.71	359.1
Gain (Loss) on Sale of Investments	-	-0.63	-	-	-
Gain (Loss) on Sale of Assets	-	-0.49	-0.13	0.46	-2.1
Other Unusual Items	-	0.18	-	0.01	0.49
Pretax Income	1,015	953.28	909.39	777.18	357.49
Income Tax Expense	288.83	273.87	283.68	243.35	111.84
Earnings From Continuing Operations	725.75	679.41	625.71	533.83	245.64
Net Income	725.75	679.41	625.71	533.83	245.64
Net Income to Common	725.75	679.41	625.71	533.83	245.64
Net Income Growth	6.82%	8.58%	17.21%	117.32%	3.18%
Shares Outstanding (Basic)	54	54	54	54	54
Shares Outstanding (Diluted)	55	55	55	55	55
Shares Change (YoY)	-0.02%	0.00%	-0.01%	0.03%	-0.02%
EPS (Basic)	13.33	12.47	11.49	9.80	4.51
EPS (Diluted)	13.31	12.46	11.47	9.79	4.51
EPS Growth	6.82%	8.63%	17.16%	117.07%	3.20%
Free Cash Flow	766.31	529.07	740.9	489.99	-9.74
Free Cash Flow Per Share	14.05	9.70	13.59	8.98	-0.18
Dividend Per Share	-	11.600	11.000	9.500	4.400
Dividend Growth	-	5.46%	15.79%	115.91%	120.00%
Gross Margin	78.41%	81.33%	83.18%	85.19%	86.37%
Operating Margin	49.27%	50.99%	52.98%	54.85%	35.47%
Profit Margin	35.82%	37.37%	37.05%	38.13%	23.72%
Free Cash Flow Margin	37.82%	29.10%	43.87%	35.00%	-0.94%
EBITDA	1,101	994.7	936.47	800.67	397.3
EBITDA Margin	54.32%	54.71%	55.45%	57.19%	38.36%
D&A For EBITDA	102.31	67.74	41.67	32.68	29.94
EBIT	998.31	926.96	894.8	768	367.37
EBIT Margin	49.27%	50.99%	52.98%	54.85%	35.47%
Effective Tax Rate	28.47%	28.73%	31.20%	31.31%	31.29%
Revenue as Reported	2,026	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.